GÖRG Partnerschaft von Rechtsanwälten mbB, led by Dr. Bernt Paudtke, has advised EUROAPI on the acquisition of all shares in BianoGMP GmbH (“Biano”).
The total consideration for the transaction is approximately €10 million, including the acquisition price (upfront payment and deferred consideration) and Capex aimed to increase Biano’s capacity to address larger scale and more complex projects.
This acquisition will strengthen EUROAPI’s CDMO market position in oligonucleotides by adding to its current offer a reputable oligonucleotide CDMO pure player, with capacity to grow. The planned expansion of EUROAPI’s Frankfurt oligonucleotide capacity in 2025 will be complementary to Biano’s early-phase expertise and enable larger-scale projects offering.
Advisors
GÖRG Partnerschaft von Rechtsanwälten mbB
Dr. Bernt Paudtke (Lead, Partner, M&A / Corporate, Munich)
Tobias Reichenberger (Associated Partner, M&A / Corporate, Munich)
Dr. Henning Wendt (Partner, Public Construction Law, Hamburg)
Dr. Ulrich Fülbier (Partner, Labour and Employment Law, Munich)
Dr. Katharina Landes (Partner, IP / IT, Cologne)
Dipl.-Kfm. Benjamin Karten (Partner, Tax, Hamburg)
Christian Müller (Associate, Tax, Hamburg)
Moritz von Limburg, LL.B, LL.M. (UCT) (Associate, M&A / Corporate, Munich)
Dr. Julian Stassek (Associate, Labour and Employment Law, Munich)
Adrian Grüner (Associate, Real Estate Law, Munich)
Sophia Hieber (Associate, Public Construction Law, Munich)
